Dimensions of Anger Reactions (DAR-5): a useful screening tool for anger in the general population.


Journal

International journal of psychiatry in clinical practice
ISSN: 1471-1788
Titre abrégé: Int J Psychiatry Clin Pract
Pays: England
ID NLM: 9709509

Informations de publication

Date de publication:
Nov 2021
Historique:
pubmed: 26 9 2020
medline: 24 12 2021
entrez: 25 9 2020
Statut: ppublish

Résumé

Dimensions of Anger Reactions (DAR-5) is a brief 5-item instrument to assess experience of anger. We aimed to verify the DAR-5 as a screening instrument in the community. A sample of 368 apparently healthy adults who attended an outpatient ambulatory facility self-reported on the DAR-5 scale, the Spielberger's State-Trait Anger Expression Inventory (STAXI), the Beck Anxiety Inventory (BAI), and the Patient Health Questionnaire (PHQ-9). Indicators of reliability and validity were calculated to demonstrate the performance of the DAR-5. According to the DAR-5, around half the respondents found themselves becoming angry with people or situations and reported persistent duration of anger. Antagonism towards others was the least frequently experienced anger (8.4%). The DAR-5 was found to be reliable and stable, showing a significant correlation with the BAI and PHQ-9 for both sexes. In confirmatory factor analysis, a one-dimensional structure of anger experience was demonstrated through salient fit statistics. A cut-off > 8 was the best threshold against STAXI for discriminating cases of anger, irrespective of sex. The shortness of the DAR-5, along with its cost-effective applicability, qualifies this measuring tool as a useful instrument for inclusion in the routine assessment of anger reactions in the general population.Key pointsThis is the first time the validity of DAR-5 has been demonstrated in a developing country.The Portuguese version of DAR-5 has appropriate sensitivity and high specificity.The DAR-5 demonstrated to be a reliable and stable instrument, irrespective of sex.

Sections du résumé

BACKGROUND BACKGROUND
Dimensions of Anger Reactions (DAR-5) is a brief 5-item instrument to assess experience of anger. We aimed to verify the DAR-5 as a screening instrument in the community.
METHODS METHODS
A sample of 368 apparently healthy adults who attended an outpatient ambulatory facility self-reported on the DAR-5 scale, the Spielberger's State-Trait Anger Expression Inventory (STAXI), the Beck Anxiety Inventory (BAI), and the Patient Health Questionnaire (PHQ-9). Indicators of reliability and validity were calculated to demonstrate the performance of the DAR-5.
RESULTS RESULTS
According to the DAR-5, around half the respondents found themselves becoming angry with people or situations and reported persistent duration of anger. Antagonism towards others was the least frequently experienced anger (8.4%). The DAR-5 was found to be reliable and stable, showing a significant correlation with the BAI and PHQ-9 for both sexes. In confirmatory factor analysis, a one-dimensional structure of anger experience was demonstrated through salient fit statistics. A cut-off > 8 was the best threshold against STAXI for discriminating cases of anger, irrespective of sex.
CONCLUSIONS CONCLUSIONS
The shortness of the DAR-5, along with its cost-effective applicability, qualifies this measuring tool as a useful instrument for inclusion in the routine assessment of anger reactions in the general population.Key pointsThis is the first time the validity of DAR-5 has been demonstrated in a developing country.The Portuguese version of DAR-5 has appropriate sensitivity and high specificity.The DAR-5 demonstrated to be a reliable and stable instrument, irrespective of sex.

Identifiants

pubmed: 32975451
doi: 10.1080/13651501.2020.1821893
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

421-429

Auteurs

Alessandra C Goulart (AC)

Health Promotion and Check-up Center, Hospital Sírio Libanês, Sao Paulo, Brasil.

Danielle Bismarchi (D)

Health Promotion and Check-up Center, Hospital Sírio Libanês, Sao Paulo, Brasil.

Marcos Rienzo (M)

Health Promotion and Check-up Center, Hospital Sírio Libanês, Sao Paulo, Brasil.

Danielli Haddad Syllos (DH)

Health Promotion and Check-up Center, Hospital Sírio Libanês, Sao Paulo, Brasil.

Yuan-Pang Wang (YP)

Instituto de Psiquiatria (LIM-23), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH